Released Nov 12, 2010, during market hours
10-Q filed Nov 12, 2010, 43 days after period end · 0001019687-10-004032
Q3 2010 · 10-Q
Revenue$6.51M$6.51M no prior Q3 2009 on file+5.1% vs Q2 2010
Net Income$124.00K$124.00K no prior Q3 2009 on fileN/M vs Q2 2010
EPS Diluted$0.00$0.00 no prior Q3 2009 on fileN/M vs Q2 2010
Operating Income$155,000—
Operating Cash Flowderived$1,335,000—
Margins · derived
Operating margin2.4%
Net margin1.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q3 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR